TD Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-64,808
| Closed | -$2.07M | – | 1526 |
|
|
2022
Q2 | $2.07M | Sell |
64,808
-7,666
| -11% | -$245K | ﹤0.01% | 997 |
|
|
2022
Q1 | $2.51M | Sell |
72,474
-32,112
| -31% | -$1.11M | ﹤0.01% | 1016 |
|
|
2021
Q4 | $3.06M | Buy |
104,586
+34,512
| +49% | +$1.01M | ﹤0.01% | 1020 |
|
|
2021
Q3 | $1.79M | Hold |
70,074
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q2 | $1.92M | Sell |
70,074
-14,782
| -17% | -$404K | ﹤0.01% | 1111 |
|
|
2021
Q1 | $3.46M | Buy |
84,856
+3,070
| +4% | +$125K | ﹤0.01% | 933 |
|
|
2020
Q4 | $3.54M | Sell |
81,786
-2,225
| -3% | -$96.4K | ﹤0.01% | 883 |
|
|
2020
Q3 | $4.63M | Sell |
84,011
-9,717
| -10% | -$536K | 0.01% | 725 |
|
|
2020
Q2 | $5.92M | Sell |
93,728
-4,854
| -5% | -$306K | 0.01% | 618 |
|
|
2020
Q1 | $5.04M | Sell |
98,582
-10,047
| -9% | -$513K | 0.01% | 620 |
|
|
2019
Q4 | $8.64M | Buy |
108,629
+24,900
| +30% | +$1.98M | 0.01% | 587 |
|
|
2019
Q3 | $4.06M | Buy |
83,729
+7,738
| +10% | +$375K | 0.01% | 732 |
|
|
2019
Q2 | $4M | Buy |
75,991
+10,496
| +16% | +$552K | 0.01% | 736 |
|
|
2019
Q1 | $3.47M | Buy |
65,495
+3,400
| +5% | +$180K | 0.01% | 782 |
|
|
2018
Q4 | $2.55M | Buy |
62,095
+634
| +1% | +$26K | ﹤0.01% | 846 |
|
|
2018
Q3 | $2.34M | Buy |
61,461
+10,800
| +21% | +$410K | ﹤0.01% | 953 |
|
|
2018
Q2 | $2.29M | Buy |
50,661
+2,600
| +5% | +$118K | ﹤0.01% | 922 |
|
|
2018
Q1 | $2.32M | Buy |
48,061
+13,986
| +41% | +$675K | ﹤0.01% | 857 |
|
|
2017
Q4 | $1.34M | Buy |
+34,075
| New | +$1.34M | ﹤0.01% | 974 |
|